MC044h, a phase II trial of sorafenib in patients (pts) with metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study

Authors
Category Primary study
Year 2007
This article has no abstract
Epistemonikos ID: 24bce609f669dec90ab3da00fc5b76d83a29fd45
First added on: Jul 22, 2020